Appendix L: Accessing/Deaccessing Implanted Central Venous Access Port

Similar documents
SPECIMEN COLLECTION. A Study Guide

Procedure 30 Collecting A Blood Specimen Using The Vacuum-Tube System. Procedure 31 Collecting A Blood Specimen Using A Needle And Syringe

#74 - CHANGING A MOIST TO DRY DRESSING (TEST)

Procedure 19 Changing A Clean Dressing. Procedure 20 Applying A Bandage. Procedure 21 Applying A Sterile Dressing

Implantable Venous Port

Revised 1/10. Copyright 2010 St. Jude Children's Research Hospital Page 1 of 5

MEDICATION AND INJECTION ADMINISTRATION EDUCATIONAL BOOKLET FOR OVULATION INDUCTION

Ventricular Assist Device (VAD) Exit Site Care Guidelines

GOAL GATHER SUPPLIES CHANGE YOUR DRESSING CALL YOUR HEALTHCARE PROVIDER:

Your Step-by-Step Guide

Migraine Attack Abortive Treatment Medication Overuse Protocol Treatment Refractory Cluster Headache Treatment

GETTING COMFORTABLE WITH TAKING STELARA

How to Give a Subcutaneous (SC) Injection to Your Child

State of Kuwait Ministry of Health Infection Control Directorate SAFE INJECTION

Administering ORENCIA (abatacept): Your Step-by-Step Guide

For Pricing and Ordering Please Call

Treatment Systemic Therapy. Your Guide to Subcutaneous Chemotherapy Self Injection

I.V. INJECTION ARM P50/1 ( ) USER MANUAL

3M Tegaderm High Performance. Foam Adhesive Dressing. Application. and Removal. Pocket Guide

TRANSGENDER HEALTH Injection Guide

Original Date:

Surgical Gown. Tongue Depressor. A disposable gown worn by medical staff during surgery. A thin, flat, wooden stick rounded at both ends

LACERATION HISTORY TAKING

LAB 5 Blood Collection

Figure A. Figure B To prevent premature activation of the needle safety guard, do not touch the NEEDLE GUARD ACTIVATION CLIPS at any time during use.

SAFETY SCREENING FORM FOR MAGNETIC RESONANCE (MR) PROCEDURES. Name (first middle last) Why are you having this examination (medical problem)?

BD Disposal Solutions Product Catalog

Do not take Neulasta if you have had a serious allergic reaction to pegfilgrastim (Neulasta ) or to filgrastim (Neupogen ).

Sterilization A Training Module

Table 6: Detailed Infection Prevention and Control Procedures for Tattooing and Micropigmentation. Use During Tattooing

Imres can offer solutions for all types of health programmes in the international relief market PROVIDING GLOBAL ACCESS TO QUALITY MEDICAL CARE

Infection Control 101

Home Care for Your Wound Drain After Breast Cancer Surgery

Urine Collection Kit. just between us. This kit contains: Before you begin! Access Key label here

LESSON ASSIGNMENT. After completing this lesson, you should be able to:

BSL-2 Emergency Plan

PURPOSE: To define the responsibilities for obtaining nipple and breast milk cultures.

Infection Prevention Guidelines. Safe Use, Handling & Disposal of Sharps

ENHANCED CONTACT AND DROPLET PRECAUTIONS PPE CHECKLIST. Trained Observer: Unit: Date: [ ] the floor. 2 Engage Trained Observer and Assistant [ ]

Medications and Medication Safety

Competency. Method of Instruction Codes. Yes / No / RDN. Yes No RDN. Yes No RDN. Yes No RDN. Yes No RDN. Yes No RDN. Yes No RDN.

Hand Hygiene. Policy Title: Hand Hygiene Policy Number: 05. Effective Date: 6/10/2013 Review Date: 6/10/2016

Instructions for Use. (dulaglutide) injection, for subcutaneous use. 1.5 mg/0.5 ml Single-Dose Pen. once weekly. Unfold and lay flat

Learning Objectives. Sutures and Staples. Training for Healthcare Professionals. Suture and Staple Removal

Dangerous Things DIY RFID Implantation Guide Written by Amal Graafstra

Brief Summary of Closing Tray Process for Cesarean Section

MESOTHERAPY PROTOCOLS

BlephEx...A Revolutionary New Treatment for Blepharitis. Owner s Manual

Lenis Needle-free Safety Syringe Device User Manual

Handling and Disposing of Needles

Topi-CLICK 140 Specifications

BD Disposal Solutions Product Catalog

Instructions For Use PRALUENT (PRAHL-u-ent) (alirocumab) Injection, for Subcutaneous Injection Single-Dose Pre-Filled Pen (75 mg/ml)

SOP BIO-002 FOR SHARPS USAGE AND DISPOSAL

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2001 H 1 HOUSE BILL 635. March 15, 2001

Home Care for Your Wound Drain

Policy: C-08-PRO Reviewed: 7/08

Ease of Use. restore for face and body. refine for more superficial treatments

Price List 2017 Latex Gloves. Non Latex Gloves. 100 boxes or more. Packaging. Examination Standard Cuff Less than 100

Instructions for use. Ixekizumab

Spot Ex Endoscopic Tattoo. Take The N Ex t Step In The Fight Against Colon Cancer

ISO Sharps injury protection Requirements and test methods Sharps containers

Hardeman County Correctional Center Whiteville, Tennessee. Inmate Mail Information. Procedures for Sending Money

Always check equipment to make sure it is in good shape. There should be no sharp edges or broken pieces.

Instructions For Use

Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers - Application of Prescribed Creams/ Ointments/ Lotions (Adult)

RULES GOVERNING BODY PIERCING TATTOO ESTABLISHMENTS

University of Alaska, Anchorage

Disposable Cartridge NOSE Piercing System

INFECTION PREVENTION AND CONTROL PLAN

3M Cavilon No Sting Barrier Film. Realize the potential of proven protection.

SUTTER COUNTY DEVELOPMENT SERVICES DEPARTMENT

The fight against infection starts at home.

Student Performance Guide. Student Performance Guide. Student Performance Guide. Student Performance Guide. LESSON 3-3 Bleeding Time

The structural simplicity of GEN1 cartridges allows room for deep significance to be carried in each of the four parts. Let s start with the tip:

MEDICAL WASTE MANAGEMENT

Implanting an Adult Rat with the Single-Channel Epoch Transmitter for Recording EEG. November 21, Epoch ECG Systems- Available from BIOPAC

Focus on Quality Care Product Resource Guide

rooo.lb IOWA COUNTY ORDINANCE NO TATTOO ARTIST REGULATIONS THE IOWA COUNTY BOARD OF SUPERVISORS DO ORDAIN AS FOLLOWS:

Dixie State University

Biohazardous Waste. 1. Solid Biohazardous Waste (non-sharps) Storage

It is unlawful to operate a tattoo shop or establishment without first obtaining a license as required by this chapter.

Disposable Cartridge NAVEL Piercing System

NHS Fife Community Services

Slide 1. Slide 2. Slide 3 EVIDENCE COLLECTION. Evidence Collection 101. Physical Evidence

METHODS OF IMPLEMENTATION AND CONTROL

Cherie Maguire, MS Research Assistant II Channing Division of Network Medicine. The Center for Clinical Investigation

Implanting an Adult Mouse with the Single-Channel Epoch Transmitter for Recording Local Field Potentials (EEG & Neural Signals)

ADVANCED WOUND CARE SL070450

Loading HepaSphere Microspheres with Lyophilized Doxorubicin

Training Manual. For the Application, Removal and Transport of the PharmChek Drugs of Abuse Patch. (The Sweat Patch is For Professional Use Only)

Lab Safety & Volume Measurement. Virtual Science University

YOUR PUMP YOUR STYLE YOUR WAY

YOUR PUMP YOUR STYLE YOUR WAY

Bloodborne Pathogens

FLORIDA GULF COAST UNIVERSITY DEPARTMENT OF REHABILITATION SCIENCES BIOSAFETY AND INFECTIOUS AGENTS CONTROL PLAN

Table 5: Detailed Infection Prevention and Control Procedures for Body Piercing. drape the piercing site.

COALINGA STATE HOSPITAL NURSING POLICY AND PROCEDURE MANUAL SECTION Infection Control POLICY NUMBER: 860. Effective Date: August 31, 2006

CONSOLIDATION UPDATE: DECEMBER 11, 2002

Transcription:

Effective Date: 03/01/2008 Page 1 of 5 Recommendations for Use Insertion Considerations Implanted Port Dressing Access/ Reaccess An implanted port is strongly recommended for patients in whom more than 6 weeks of vascular access is anticipated and for whom a PICC may not be appropriate (chemotherapy, CPN). Implanted ports shall only be placed in CVIL/IRC or the operating room (OR) Ports shall be re-accessed within a sterile field using a new Huber needle every 7 days; the needle, extension tubing and dressing shall be changed at that time (requires documented competency). Where applicable, VAT shall be notified to access and follow patients with implanted ports for the every 7 day reaccess and dressing change. (See below for Power Injectable Port procedure) Implanted Port Access/ Reaccess 1. Obtain authorized prescriber order to access implanted port 2. Assess patients pain tolerance and previous experience with port accessing and need for transdermal anesthetic cream 3. Obtain authorized prescriber order for transdermal anesthetic cream for application to skin over accessing area, if indicated. 4. Identify patient 5. Assess location of port and septum to be accessed, note any redness, edema, pain or drainage and report any of these to the authorized prescriber 6. Explain procedure to patient 7. Assess appropriate Huber (non-coring) needle size based on location of port septum and patient body type (patient may be aware of their usual needle gauge and length). Never use any other needle to access an implanted port, coring of the septum can occur causing damage. Available sizes and lengths of Huber Plus Safety Needles. 22G- 1/2 inch, 22G- 3/4 inch,22g- 1 inch, 22G- 1 1/2 inch 20 G- 3/4 inch, 20G - 1 inch, 20G- 1 1/4 inch, 20G - 1 1/2 inch 8. For first attempt, if previous needle size is undeterminable, utilize a 22 gauge, 1 ½ inch Huber needle 9. Ideally, the 90 degree turn of the Huber shall rest as close to the skin as possible. A gap greater than ¼ inch indicates a shorter needle shall be utilized for future accessing. 10. Apply transdermal anesthetic cream 1 hour prior to accessing and cover with a transparent dressing.

Effective Date: 03/01/2008 Page 2 of 5 a. Thoroughly remove transdermal cream with a sterile 2x2 gauze pad prior to cleansing port in preparation for accessing 11. Gather supplies 12. Wash hands thoroughly and palpate infusion port with clean gloves on 13. Apply mask to patient and self 14. Open sterile gloves 15. Utilize inside of sterile glove wrapper as a sterile field a. Drop Chloraprep, tegaderm dressing, needleless valve, skin prep, one empty sterile 10-cc syringe, and one sterile Huber needle of appropriate size onto sterile field b. Open second set of sterile gloves c. Open three syringes of prefilled normal saline (do not place on sterile field) 16. Remove clean gloves 17. Don sterile gloves a. Remove cap on end of sterile Huber needle connection tubing b. With non-dominant hand, hold sterile Huber needle connection tubing in preparation for priming c. With dominant hand, attach prefilled syringe (which is not sterile) to Huber needle connection tubing and prime Huber needle d. With the non-dominant hand, lay primed Huber needle and tubing on sterile field (with non-sterile syringe only touching outer area of sterile field) e. Clamp Huber needle connection tubing f. Remove syringe g. Maintain Huber needle and connection tubing on sterile filed at all times 18. Don new sterile gloves a. Attach empty sterile 10cc to Huber needle connection tubing b. Cleanse skin over port with Chloraprep, using a scrubbing motion while cleaning in concentric circles c. Allow Chloraprep to dry for 60 seconds d. Grasp edge of port with non-dominant hand to stabilize the port e. Insert the Huber needle into the center of the port septum going through the skin at a 90-degree angle. Apply steady pressure until the needle touches the base of the port reservoir. f. Aspirate to check for a blood return g. Attach needleless valve to end of Huber connection tubing 19. Apply skin prep 20. Apply Tegaderm dressing 21. Flush Huber needle connection tubing with 20 cc normal saline (per VAD policy) 22. Attach IV tubing 23. If unsuccessful port access, repeat above steps for reaccess attempt 24. If still unsuccessful, notify VAD team member for consultation De-Access 1. Obtain authorized prescriber order to access implanted port 2. Identify patient 3. Explain procedure to patient 4. Gather supplies

Effective Date: 03/01/2008 Page 3 of 5 5. Wash hands thoroughly 6. Apply mask to patient and self 7. Open a sterile gauze 2x2 pad or a sterile band aid 8. Don clean gloves a. Flush port catheter with 20 cc normal saline b. Heparin lock port catheter with appropriate amount of heparin per VAD policy c. Remove dressing d. Use non-dominant hand to stabilize port e. Using dominant hand, gently remove Huber needle using safety needle device per manufacturers guidelines f. Discard Huber needle in sharps container g. Cover site with dry sterile gauze dressing or band aid Blood Draws (see Adult VAD policy) Flush Solution: Volume: Frequency: Flush for Port* (*Call VAT when a patient with a port is admitted or scheduled for discharge, where applicable) NSS Flush 20 ml NSS each lumen 1. After blood sampling 2. Before and after incompatible medications or fluids 3. Wehn converting from continuous to intermittent use 4. When not in in continuous use: a. after fluids/ medications 5. At least daily Following NSS Flush and WHEN ORDERED BY AUTHORIZED PRESCRIBER: Heparin Lock: 6 ml Heparin (10 units/ml) each lumen 1. After blood sampling 2. When converting from continuous to intermittent use 3. When not in continuous use: a. after fluids/ medications 4. At least daily Flush Solution/Medication Dose/Volume Frequency: Port De-Accessing* (Needle Removal) NSS Flush 20 ml NSS Whenever de-accessing port Heparin Lock: 6 ml Heparin 100 units/ml Whenever de-accessing port

Effective Date: 03/01/2008 Page 4 of 5 Following NSS Flush and WHEN ORDERED BY AUTHORIZED PRESCRIBER: Power Injectable Port: Recommendations for Use The Power Port is the first implantable port indicated for power injection when used with Power Loc Safety Infusion Set. Available size and length of this needle (20g x1inch) This port allows contrast dye to be power-injected for patients having a CT scan. It is also MRI safe. The power port also has a radiographic plate on the back which can be distinguished on a chest X ray by an authorized prescriber. Implanted Power Injectable Port Access/ Re-access (Power Injectable Ports are only accessed with a Power Loc Safety Infusion Set by the following individuals who have received competency training: JHH Venous Access Team, Oncology PICC Team, Oncology CNS'S, Oncology OPD RNs Radiology RNs) 1. The trained and competent practitioner accessing the port must verify that the patient has an implanted power port device using at least two validation points: a. Feel for triangular shaped port b. Feel for three palpation points (bumps) on the port septum c. Verify patient has a Power Port device patient ID card d. Verify via radiographic study that patient has a Power Port. e. Document at least two validation points in the patient s medical record. f. Validate presence of blood return prior to use g. Place device verification sticker on infusion set indicating that the port is a power port. 2. After validating presence of a Power Port access port and only using the power loc safety infusion set, follow Access/De-access procedure above. Procedure for flushing, as above, remains the same. 3. Nurses who are trained and competent in accessing non-power Port implanted central venous access ports MAY access a Power Port with a regular Huber needle (non- Power Loc), if necessary.

Effective Date: 03/01/2008 Page 5 of 5